title: A workshop on pubertal hormone replacement options in the United States.
abstract: BACKGROUND
  The optimal pubertal hormone replacement therapy in females and males is unclear.
  
  
  OBJECTIVE
  To review hormone replacement options for hypogonadal teenagers and to determine the relevant attitudes and practices of pediatric endocrinologists in the United States.
  
  
  METHODS
  A workshop on pubertal hormone replacement options was held during the Lawson Wilkins Pediatric Endocrine Society meeting in 2004. A questionnaire was distributed to investigate the audience's attitudes and practices in inducing puberty.
  
  
  RESULTS
  The majority of respondents used conjugated estrogens to treat hypogonadal girls with the primary aim of treatment being attainment of maximal adult height. The majority of respondents used depot testosterone to treat hypogonadal boys with the primary aim of treatment being pubertal development and virilization.
  
  
  CONCLUSIONS
  The use of physiological sex hormone replacement to optimize the induction of puberty in hypogonadal adolescents was recommended. The workshop revealed striking differences between US and European pediatric endocrinologists regarding their practices and attitudes regarding the induction of puberty in hypogonadal females. Detailed studies are necessary to develop more uniform guidelines.
authors.affiliation: Department of Pediatrics, University of Chicago, IL, USA.
authors.forename: Stephanie
authors.initials: S
authors.lastname: Drobac
authors.forename: Karen
authors.initials: K
authors.lastname: Rubin
authors.forename: Alan D
authors.initials: AD
authors.lastname: Rogol
authors.forename: Robert L
authors.initials: RL
authors.lastname: Rosenfield
mesh_terms: D000293:Adolescent; D000328:Adult; D001827:Body Height / Q000187:drug effects*; D002648:Child; D004493:Education; D004704:Endocrinology / Q000379:methods / Q000706:statistics & numerical data; D004967:Estrogens / Q000627:therapeutic use; D005060:Europe; D005260:Female; D020249:Hormone Replacement Therapy / Q000379:methods* / Q000706:statistics & numerical data; D006801:Humans; D007006:Hypogonadism / Q000188:drug therapy*; D008297:Male; D010372:Pediatrics / Q000379:methods / Q000706:statistics & numerical data; D011627:Puberty / Q000187:drug effects; D011628:Puberty, Delayed / Q000188:drug therapy*; D011795:Surveys and Questionnaires; D013739:Testosterone / Q000627:therapeutic use; D014481:United States
chemical_list: D004967:Estrogens; D013739:Testosterone